0000950170-24-079717.txt : 20240701 0000950170-24-079717.hdr.sgml : 20240701 20240701165448 ACCESSION NUMBER: 0000950170-24-079717 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240701 FILED AS OF DATE: 20240701 DATE AS OF CHANGE: 20240701 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Reilly Thomas Charles CENTRAL INDEX KEY: 0001827590 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-21392 FILM NUMBER: 241091479 MAIL ADDRESS: STREET 1: C/O CARA THERAPEUTICS, INC. STREET 2: 4 STAMFORD PLAZA, 107 ELM STREET CITY: STAMFORD STATE: CT ZIP: 06902 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AMARIN CORP PLC\UK CENTRAL INDEX KEY: 0000897448 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: X0 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: SPACES SOUTH DOCKLANDS, BLOCK C STREET 2: 77 SIR JOHN ROGERSON'S QUAY CITY: DUBLIN 2 STATE: L2 ZIP: D02 VK60 BUSINESS PHONE: 353 1 6699 020 MAIL ADDRESS: STREET 1: SPACES SOUTH DOCKLANDS, BLOCK C STREET 2: 77 SIR JOHN ROGERSON'S QUAY CITY: DUBLIN 2 STATE: L2 ZIP: D02 VK60 FORMER COMPANY: FORMER CONFORMED NAME: AMARIN PHARMACEUTICALS PLC DATE OF NAME CHANGE: 20000201 FORMER COMPANY: FORMER CONFORMED NAME: ETHICAL HOLDINGS PLC DATE OF NAME CHANGE: 19930322 4 1 ownership.xml 4 X0508 4 2024-07-01 0000897448 AMARIN CORP PLC\UK AMRN 0001827590 Reilly Thomas Charles C/O AMARIN PHARMA, INC. 440 US HIGHWAY 22 BRIDGEWATER NJ 08807 false true false false EVP and CFO false Ordinary Shares 2024-07-01 4 M false 16667 A 102514 D Ordinary Shares 2024-07-01 4 F false 8209 0.69 D 94305 D Restricted Stock Unit 0.00 2024-07-01 4 M false 16667 0.00 D Ordinary Shares 16667 16666 D The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. On February 21, 2023, the Issuer's Remuneration Committee of its Board of Directors certified the achievement of certain performance metrics for this Restricted Stock Unit ("RSU") award, resulting in the grant of 50,000 RSUs scheduled to vest in three equal installments on each of the first, second and third anniversary of the grant date of July 1, 2022, subject to the Reporting Person's continued service to the Issuer. Not applicable Represents withholding by the Issuer of shares in respect of tax liability incident to the vesting of a security issued in accordance with Rule 16b-3, and not a market sale of securities. Each RSU represents a contingent right to receive one Ordinary Share or cash in lieu thereof at the Issuer's discretion. /s/ Tom Reilly 2024-07-01